Intelimedix, TC3 Health announce strategic partnership

NewsGuard 100/100 Score

Intelimedix, a business intelligence company focused on multi-relational data mining and advanced analytics for faster, more accurate decision-making, announced a strategic partnership with integrated loss control service provider TC3 Health, Inc.

The strategic partners will combine their core capabilities to offer public and private health plans a comprehensive medical cost-management solution that includes identification of preventable conditions and unnecessary treatment, clinical code editing, and fraud, waste, and abuse detection.  Imbedded in the workflow is the disposition of improper transactions through pre-payment investigative and retrospective recovery services.  

The integrated solution is powered by Intelimedix's market-leading data mining and analytics platform, which leverages proprietary deterministic algorithms to uncover inappropriate payments, known fraud schemes and treatment variations, as well as other cost-increasing events. Intelimedix's predictive modeling capability employs profiling and pattern recognition to detect such problems as provider fraud, member misuse and identity theft.

The integration of Intelimedix's analytics platform with TC3's proprietary fraud detection and code edit compliance engine will provide a complete pre-pay and post-pay cost control solution. By combining these complementary capabilities, Intelimedix and TC3 supply a powerful vehicle for identifying, investigating, preventing and recovering inappropriate payments, adding the practical means for companies to stop or reclaim incorrectly paid benefit dollars.  

"When you couple TC3's frontline experience in pre-payment fraud, waste and abuse control with Intelimedix's detection technology and decision analytics, you get a cost containment solution that can respond as quickly as the schemes emerge," said Intelimedix President and CEO Joel Portice. "Our partnership delivers real substance to health plans with the capability to accurately identify new patterns and cost savings."

"Both new and existing customers of our respective companies will gain substantial value from this partnership," added TC3 President and CEO Doug Chisholm. "Together, we deliver a comprehensive, technology-driven solution that protects the healthcare payer's bottom line as it conserves policyholder benefit dollars."

Source:

TC3 Health, Inc.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations